Results 221 to 230 of about 158,836 (338)
Letter Re: Butyrylcholinesterase is a potential biomarker for sudden infant death syndrome. [PDF]
Harrington CT, Hafid NA, Waters KA.
europepmc +1 more source
Abstract Objective This randomized, double‐blind, phase 1b/2a clinical trial was designed to evaluate the safety, tolerability, and efficacy of oral bexicaserin versus placebo for the treatment of seizures in adolescents and adults with developmental and epileptic encephalopathies (DEEs).
Dennis J. Dlugos +74 more
wiley +1 more source
Global, regional, and national burden of sudden infant death syndrome, 1990-2021: a comprehensive analysis of GBD 2021 data with insights into the impact during the COVID-19 pandemic. [PDF]
Sun Y +5 more
europepmc +1 more source
Abstract Lennox–Gastaut syndrome (LGS) is one of the most severe, yet one of the most discussed, childhood‐onset developmental and epileptic encephalopathies (DEEs). Dissent among epileptologists on the definition and minimum set of electroclinical features derives from the high etiological heterogeneity within the syndrome, which could make its ...
Antonella Riva +40 more
wiley +1 more source
Abstract Objective This study investigated whether scalp high‐frequency activity (HFA) rates in neonates with seizures predict postneonatal epilepsy (PNE). It also assessed whether HFA rates differentiate neonates with seizures from healthy neonates and whether they vary by seizure etiology, therapeutic hypothermia, and electroencephalographic (EEG ...
Panagiota Karatza +6 more
wiley +1 more source
Genetic Association Study of Acetylcholinesterase (ACHE) and Butyrylcholinesterase (BCHE) Variants in Sudden Infant Death Syndrome (SIDS). [PDF]
Qu D +4 more
europepmc +1 more source
The role of neglect in child fatality and serious injury [PDF]
Blair +29 more
core +1 more source

